Services
Expertises
Resources
Who we are
Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 - Canada
Closed
Source verified July 9, 2026

Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024

Biopharmaceutical collaboration mission to Germany
Funding available
Varies by project
Deadline
June 14, 2024
Location
Canada
Who can apply

Small and medium-sized enterprises.

See full eligibility

Overview

The Canadian biopharmaceuticals co-innovation mission to Germany takes place from November 3 to 8, 2024 and is open to small and medium-sized enterprises in the biopharmaceuticals sector. It focuses on collaboration in advanced therapies, drug delivery, antibody-based therapeutics, companion diagnostics, and biomanufacturing enabling technologies.
/100
Opportunity Score
Moderate potential, but conditions must align.

At a glance

Funding available

Financing goals
  • Develop strategic partnerships
  • Conduct research and development activities
  • Access new markets
Eligible Funding
  • Varies by project

Eligible candidates

Eligible Industries
  • All industries
Location
  • Canada
Legal structures
  • For-profit business
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • All groups

Next Steps

1
Determine your project
2
Validate your eligibility

Official resources

Official page

Canadian biopharmaceuticals co-innovation mission to Germany - November 3 to 8, 2024

Eligibility

Who is eligible?

  • Small and medium-sized enterprises.

Additional information

  • The page is archived and will not be updated.
  • Related program: Canadian International Innovation Program.

Contacts

Other components of this program

Explore related funding streams and grants that belong to the same program.

Frequently Asked Questions about the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 Program

What is the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024?

The Canadian biopharmaceuticals co-innovation mission to Germany takes place from November 3 to 8, 2024 and is open to small and medium-sized enterprises in the biopharmaceuticals sector. It focuses on collaboration in advanced therapies, drug delivery, antibody-based therapeutics, companion diagnostics, and biomanufacturing enabling technologies.

Who is eligible for the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 program?

To be eligible for the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 program, you must: Open to small and medium-sized enterprises.

Who can I contact for more information about the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024?

You can contact National Research Council Canada (NRC) by email at none or by phone at none.

Where is the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 available?

The Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 program is available across Canada.

Is the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 a grant, loan, or tax credit?

Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 is a Partnering and Collaboration

Who are the financial supporters of the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024?

Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 is funded by National Research Council Canada (NRC)